8-K filing — Lineage Cell Therapeutics, Inc. (LCTX)
Filed: 2026-08-06 AccNo: 0001193125-26-338020 Size: 793 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Lineage Cell Therapeutics Updates COR1 Corneal Cell Transplant Program; Highlights Scalable Allogeneic Production Via AlloSCOPE Platform And Plans Conference Call Today
Company Will Host Conference Call Today at 4:30 PM ET / 1:30 PM PTCOR1 Aims to Provide an "Off the Shelf" Supply of Allogeneic CEnCs for Patients Suffering from Corneal Endothelial DiseaseUtilizes the Company’s
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 13, 2026, 12:08 PM
- Checked
- Jul 13, 2026, 12:08 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading